TapewireFind a company

person · Reporting owner

Ben-David Zvi

Disclosed activity across 1 company

Tapewire entity
93311
SEC CIK
0001667943

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
DarioHealth Corp.DRIO · Entity 7024Chief Financial OfficerMarch 06, 2024March 08, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DarioHealth Corp.

Report date March 06, 2024 · Filed March 08, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect746,035 Reported balance After 2024-03-06 transaction · row 1
1 source row

Row 1 · 2024-03-06 · Grant · Acquired 400,000 · Balance 746,035

F1: The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in quarterly instalments on the last day of each calendar quarter commencing March 31, 2024 for a two year period.

Common StockSEC Table I · non-derivativeIndirectBy spouse1,786 Reported balance Holding disclosure · report date 2024-03-06 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 1,786

F2: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in quarterly instalments on the last day of each calendar quarter commencing March 31, 2024 for a two year period.

F2: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 06, 2024 Filed Mar 8, 2024 16:24 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 400,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-032416 · tm248350-9_4seq1.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 746,035

F1 · date: The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in quarterly instalments on the last day of each calendar quarter commencing March 31, 2024 for a two year period.

Read SEC document
May 18, 2022 Filed May 20, 2022 17:04 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 95,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-063457 · tm2216123-10_4seq1.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 346,035

F1 · shares: The shares vest over three years as follows: 8.333% shall vest after 3 months from the grant date, and the remaining shares vest in 11 equal instalments every 3 months thereafter.

Read SEC document
October 10, 2021 Filed Oct 12, 2021 16:46 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 369 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-125375 · tm2129692d3_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,035

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2021.

Read SEC document
July 18, 2021 Filed Jul 20, 2021 16:31 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 365 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-093989 · tm2122591-4_4seq1.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,666

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the third quarter of 2021.

Read SEC document
May 03, 2021 Filed May 5, 2021 16:06 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 357 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-061709 · tm2115112d3_4seq1.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,301

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the second quarter of 2021.

Read SEC document
January 19, 2021 Filed Jan 21, 2021 16:09 UTC DarioHealth Corp. DRIO · Entity 7024 GrantRestricted Stock Grant 111,228 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-006300 · tm213677-9_4seq1.xml · nonDerivative · entry 2

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 249,944

F2 · date: The shares vest over three years as follows: 8.333% shall vest on March 31, 2021, and the remaining shares vest in 11 equal instalments every 3 months thereafter.

Read SEC document
January 19, 2021 Filed Jan 21, 2021 16:09 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 1,152 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-006300 · tm213677-9_4seq1.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,716

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2021.

Read SEC document
October 16, 2020 Filed Oct 20, 2020 16:07 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 6,241 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-116427 · tm2033754d2_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,564

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2020, and for additional compensation waived between April 2020 and July 2020.

Read SEC document
September 08, 2020 Filed Sep 10, 2020 16:06 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-103942 · tm2030511d3_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,323

F1 · shares: The reporting person was awarded such securities under the Issuer's Amended and Restated 2012 Equity Incentive Plan.

Read SEC document
July 20, 2020 Filed Jul 22, 2020 16:07 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 7,283 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-085621 · tm2025176d1_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,323

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the third quarter of 2020.

Read SEC document
April 03, 2020 Filed Apr 7, 2020 16:08 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 7,074 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-044162 · tm2015091d11_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,040

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the second quarter of 2020.

Read SEC document
February 12, 2020 Filed Feb 14, 2020 16:15 UTC DarioHealth Corp. DRIO · Entity 7024 GrantStock Option (right to buy) · Derivative 27,827 $0.00 Strike: $7.74 $0.00
Disclosure

SEC source: 0001104659-20-021774 · tm207834-8_4.xml · derivative · entry 3

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,827

Underlying: Common Stock · 27,827 shares

Expires 2026-02-12

F2 · derivative.exercise_date: The options will vest in twelve equal quarterly installments over a three year period commencing on February 10, 2020, subject to the Director's continued employment by the company. The option will not be subject to section 6(i) (Termination for Continuous Services) of the Plan and will be exercisable until its expiration date on the sixth anniversary from its grant date.

Read SEC document
February 12, 2020 Filed Feb 14, 2020 16:15 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 45,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-021774 · tm207834-8_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,966

Read SEC document
January 28, 2020 Filed Jan 30, 2020 16:07 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 7,287 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-008692 · tm206156d11_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,966

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2020.

Read SEC document
December 23, 2019 Filed Dec 26, 2019 16:10 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 7,218 $0.00 $0.00
Disclosure

SEC source: 0001104659-19-076128 · tm1927375-11_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,679

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2019 in the aggregate amount of $31,111.44.

Read SEC document
July 09, 2019 Filed Jul 10, 2019 16:05 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 100,397 $0.00 $0.00
Disclosure

SEC source: 0001144204-19-034296 · tv524959_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 949,151

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the second and third quarters of 2019 in the aggregate amount of $60,238.34.

Read SEC document
April 29, 2019 Filed Apr 30, 2019 17:01 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 139,252 $0.00 $0.00
Disclosure

SEC source: 0001144204-19-022455 · tv520221_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 848,754

F1 · shares: Of the amount shown, 41,474 shares were awarded in lieu of a cash bonus compensation for the fiscal year of 2018 in the amount of $41,474.56.

Read SEC document
January 27, 2019 Filed Jan 29, 2019 16:03 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 28,943 $0.00 $0.00
Disclosure

SEC source: 0001144204-19-003516 · tv511870_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 709,502

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2019 in the amount of $28,943.77.

Read SEC document
October 03, 2018 Filed Oct 5, 2018 16:20 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 30,075 $0.00 $0.00
Disclosure

SEC source: 0001144204-18-052742 · tv504210_form4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 680,559

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2018 in the amount of $29,893.40.

Read SEC document
July 09, 2018 Filed Jul 10, 2018 16:05 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 22,279 $0.00 $0.00
Disclosure

SEC source: 0001144204-18-037835 · tv498253_form4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 650,484

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the second quarter of 2018 in the amount of $2,622.94, and for the third quarter of 2018 in the amount of $29,819.41.

Read SEC document
June 06, 2018 Filed Jun 8, 2018 16:08 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 177,543 $0.00 $0.00
Disclosure

SEC source: 0001144204-18-033547 · tv496164_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 628,205

F1 · shares: Of the amount shown, 21,682 shares were awarded in lieu of a cash bonus compensation for the fiscal year of 2017 in the amount of $37,488.59.

Read SEC document
April 23, 2018 Filed Apr 25, 2018 16:05 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 14,896 $0.00 $0.00
Disclosure

SEC source: 0001144204-18-022368 · tv491859_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,662

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the second quarter of 2018 in the amount of $22,950.77.

Read SEC document
February 28, 2018 Filed Mar 2, 2018 16:07 UTC DarioHealth Corp. DRIO · Entity 7024 PurchaseWarrant to purchase Common Stock · Derivative 28,573 $0.00 Strike: $1.80 $0.00
Disclosure

SEC source: 0001144204-18-012533 · tv487625_form4.xml · derivative · entry 4

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 28,573

Underlying: Common Stock · 28,573 shares

Expires 2019-08-28

F1 · shares: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · price: The Warrants were issued in connection with the purchase of the Common Stock and the Series C Convertible Preferred Stock reported herein.

F1 · balance_after: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
February 28, 2018 Filed Mar 2, 2018 16:07 UTC DarioHealth Corp. DRIO · Entity 7024 PurchaseSeries C Convertible Preferred Stock · Derivative 13,349 $2.80 Strike: $1.40 $37,377.20
Disclosure

SEC source: 0001144204-18-012533 · tv487625_form4.xml · derivative · entry 3

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 13,349

Underlying: Common Stock · 26,698 shares

Expires not disclosed

F1 · shares: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · derivative.exercise_date: The Series C Convertible Preferred Stock automatically converts into Common Stock on a 1:2 basis upon shareholder approval of the conversion and has no expiration date.

F2 · derivative.expiration_date: The Series C Convertible Preferred Stock automatically converts into Common Stock on a 1:2 basis upon shareholder approval of the conversion and has no expiration date.

F1 · balance_after: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
February 28, 2018 Filed Mar 2, 2018 16:07 UTC DarioHealth Corp. DRIO · Entity 7024 PurchaseCommon Stock 9,018 $1.40 $12,625.20
Disclosure

SEC source: 0001144204-18-012533 · tv487625_form4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 9,018

F1 · shares: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F1 · balance_after: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
January 04, 2018 Filed Jan 8, 2018 16:16 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 14,839 $0.00 $0.00
Disclosure

SEC source: 0001144204-18-001307 · tv482697_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 435,766

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2018 in the amount of $23,888.38.

Read SEC document
October 23, 2017 Filed Oct 25, 2017 16:08 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 12,325 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-054099 · tv477612_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420,927

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2017 in the amount of $22,879.23.

Read SEC document
July 10, 2017 Filed Jul 11, 2017 16:09 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 9,938 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-036441 · v470581_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 408,602

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the third quarter of 2017 in the amount of $22,976.89.

Read SEC document
April 20, 2017 Filed Apr 21, 2017 16:15 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-021531 · v464821_form4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 398,664

F1 · shares: The reporting person was awarded such securities as a bonus for the 2016 fiscal year.

Read SEC document
April 13, 2017 Filed Apr 17, 2017 16:17 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 6,049 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-020712 · v464364_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 378,664

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the second quarter of 2017 in the amount of $22,138.96.

Read SEC document
January 30, 2017 Filed Feb 1, 2017 16:06 UTC DarioHealth Corp. DRIO · Entity 7024 GrantStock Option (right to buy) · Derivative 31,823 $0.00 Strike: $3.20 $0.00
Disclosure

SEC source: 0001144204-17-005355 · v457880_4.xml · derivative · entry 3

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,823

Underlying: Common Stock · 31,823 shares

Expires 2023-01-30

F2 · derivative.exercise_date: The option vests in twelve equal quarterly installments commencing on January 30, 2017.

Read SEC document
January 30, 2017 Filed Feb 1, 2017 16:06 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 6,639 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-005355 · v457880_4.xml · nonDerivative · entry 2

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 372,615

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the first quarter of 2017 in the amount of $21,258.77.

Read SEC document
January 30, 2017 Filed Feb 1, 2017 16:06 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 74,896 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-005355 · v457880_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 365,976

Read SEC document
January 12, 2017 Filed Jan 13, 2017 16:50 UTC DarioHealth Corp. DRIO · Entity 7024 GrantCommon Stock 6,536 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-002222 · v456905_4.xml · nonDerivative · entry 1

Ben-David Zvi · CIK 0001667943 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,080

F1 · shares: The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2016 in the amount of $20,977.08.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.